X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28) 28
index medicus (28) 28
female (26) 26
male (25) 25
adult (15) 15
aged (15) 15
middle aged (15) 15
oncology (9) 9
aged, 80 and over (8) 8
adolescent (7) 7
cancer (7) 7
analysis (6) 6
chemotherapy (6) 6
child, preschool (6) 6
prognosis (5) 5
research (5) 5
child (4) 4
cohort studies (4) 4
diagnosis (4) 4
disease progression (4) 4
hiv (4) 4
immunology (4) 4
infectious diseases (4) 4
medicine (4) 4
patients (4) 4
prospective studies (4) 4
risk factors (4) 4
young adult (4) 4
antiretroviral therapy (3) 3
children (3) 3
cirrhosis (3) 3
critical care medicine (3) 3
drug therapy (3) 3
epidemiology (3) 3
further section (3) 3
hematology (3) 3
immunotherapy (3) 3
infant, newborn (3) 3
intensive-care-unit (3) 3
lung cancer (3) 3
mechanisms (3) 3
medical research (3) 3
medicine, research & experimental (3) 3
mortality (3) 3
pharmacology & pharmacy (3) 3
physicians (3) 3
polymorphism, single nucleotide (3) 3
radiology, nuclear medicine & medical imaging (3) 3
severity of illness index (3) 3
studies (3) 3
survival (3) 3
treatment outcome (3) 3
urology & nephrology (3) 3
usage (3) 3
5-fluorouracil (2) 2
activation (2) 2
administration, oral (2) 2
aids-related opportunistic infections (2) 2
algorithms (2) 2
anesthesiology (2) 2
anti-retroviral agents - therapeutic use (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
article (2) 2
biological response modifiers (2) 2
biomarkers, tumor - blood (2) 2
cancer patients (2) 2
capecitabine (2) 2
carcinoma (2) 2
care and treatment (2) 2
cell biology (2) 2
cell survival (2) 2
cells (2) 2
chromosomes (2) 2
chronic disease (2) 2
chronic hepatitis-c (2) 2
clinical trials (2) 2
comorbidity (2) 2
computer-assisted instruction (2) 2
critically-ill patients (2) 2
delirium (2) 2
determinants (2) 2
development and progression (2) 2
diagnostic systems (2) 2
disease (2) 2
drug therapy, combination (2) 2
education, medical, continuing (2) 2
expression (2) 2
fibrosis (2) 2
fluorouracil (2) 2
fluorouracil - administration & dosage (2) 2
fluorouracil - therapeutic use (2) 2
follow-up (2) 2
genotype (2) 2
glomerular-filtration-rate (2) 2
graft (2) 2
hepatitis (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Oncology, ISSN 1470-2045, 06/2018, Volume 19, Issue 6, pp. 737 - 746
Despite the acknowledged sex-related dimorphism in immune system response, little is known about the effect of patients' sex on the efficacy of immune... 
CELL LUNG-CANCER | PHASE-III TRIAL | CHECKPOINT INHIBITORS | ONCOLOGY | ADVANCED MELANOMA | DOUBLE-BLIND | GENDER | NIVOLUMAB | T-CELLS | IPILIMUMAB | CHEMOTHERAPY | Cancer patients | Care and treatment | Analysis | Immunotherapy | Metastasis | Drug therapy | Lung cancer, Non-small cell | Cancer
Journal Article
The Lancet Oncology, ISSN 1470-2045, 08/2018, Volume 19, Issue 8, pp. e380 - e381
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 4/2007, Volume 59, Issue 5, pp. 637 - 642
Journal Article
Journal Article
Respiratory Medicine, ISSN 0954-6111, 10/2017, Volume 131, pp. 1 - 5
COPD frequently coexists with HF with which shares several risk factors. A greater collaboration is required between cardiologists and pulmonologists to better... 
Pharmacological treatment | Diagnostic workup | Comorbidity | Risk factors | COPD | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | CLINICAL CHARACTERISTICS | CHALLENGES | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | CONSEQUENCES | VENTRICULAR DYSFUNCTION | BURDEN | Bronchodilator Agents - therapeutic use | Spirometry | Prevalence | Humans | Male | Practice Patterns, Physicians | Muscarinic Antagonists - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Pulmonary Disease, Chronic Obstructive - epidemiology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | General Practice | Aged, 80 and over | Female | Heart Failure - diagnosis | Retrospective Studies | Hypertension - epidemiology | Platelet Aggregation Inhibitors - therapeutic use | Heart Failure - epidemiology | Adrenergic beta-Antagonists - therapeutic use | Pulmonary Disease, Chronic Obstructive - diagnosis | General Practitioners | Administration, Inhalation | Heart Failure - drug therapy | Smoking - epidemiology | Diabetes Mellitus - epidemiology | Diuretics - therapeutic use | Aged | Disease Management | Pulmonary Disease, Chronic Obstructive - drug therapy | Heart failure | Lung diseases, Obstructive | Physicians (General practice) | Analysis | Mortality | Heart | Therapy | Smoke | Data bases | Bronchodilators | Diuretics | Population | Chronic obstructive pulmonary disease | Heart diseases | Hypertension | EKG | Statistical analysis | Diabetes mellitus | Pharmacology | Risk analysis | Patients | Quality of life | Inhibitors | Medical prognosis | Diagnostic systems | Diabetes | Health risk assessment | Cigarette smoke
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 08/2001, Volume 117, Issue 2, pp. 326 - 332
Journal Article
International Journal of Biological Markers, ISSN 0393-6155, 01/2018, Volume 33, Issue 1, pp. 55 - 61
Background: Recently, pro-gastrin-releasing peptide (pro-GRP) became available as an alternative sensitive, specific and reliable tumor marker for patients... 
SCLC | Pro-GRP | Marker | SURVIVAL | NSE | DIAGNOSIS | CARCINOEMBRYONIC ANTIGEN CEA | GASTRIN-RELEASING-PEPTIDE | IMMUNOHISTOCHEMICAL MARKERS | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | NEURON-SPECIFIC ENOLASE | CARCINOMA | TUMOR-MARKER
Journal Article
Genome Announcements, ISSN 2169-8287, 2017, Volume 5, Issue 35
We present here the full-length genome sequences of two hepatitis E virus genotype 3 (HEV-3) isolates from a human stool sample from a patient with acute... 
Journal Article
World Neurosurgery, ISSN 1878-8750, 12/2017, Volume 108, pp. 291 - 302
PHACE syndrome (Posterior fossa malformations, large cervicofacial infantile Hemangiomas, Arterial anomalies, aortic coarctation and Cardiac abnormalities, and... 
Encephalomyosynangiosis | PHACE syndrome | Brain MRI | Encephaloduroarteriosynangiosis | Quasi-moyamoya disease | SURGERY | REVASCULARIZATION | ARTERIAL ANOMALIES | CEREBRAL VASCULOPATHY | CLINICAL NEUROLOGY | CHILDREN | POSTERIOR-FOSSA | DISEASE | HEMANGIOMAS | Stroke (Disease) | Eye diseases | Congenital heart disease
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 09/2015, Volume 80, Issue 3, pp. 581 - 588
Aims Triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan is a standard therapy for metastatic colorectal cancer (CRC). Single nucleotide... 
colorectal cancer | irinotecan | single nucleotide polymorphisms | pharmacogenetics | fluoropyrimidines | 1ST-LINE TREATMENT | LEUCOVORIN | BEVACIZUMAB | GUIDELINES | TOXICITY | FLUOROURACIL | CAPECITABINE | 5-FLUOROURACIL | FOLFOXIRI | PHARMACOLOGY & PHARMACY | EXPRESSION | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Fluorouracil - therapeutic use | Glucuronosyltransferase - genetics | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Dihydropyrimidine Dehydrogenase Deficiency - genetics | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Leucovorin - therapeutic use | Camptothecin - analogs & derivatives | Dihydropyrimidine Dehydrogenase Deficiency - etiology | Camptothecin - adverse effects | Glucuronosyltransferase - deficiency | Camptothecin - therapeutic use | Homozygote | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Heterozygote | Aged | MicroRNAs - genetics | Polymorphism, Single Nucleotide | Organoplatinum Compounds - therapeutic use | Dihydrouracil Dehydrogenase (NADP) - genetics | Organoplatinum Compounds - adverse effects | Antimitotic agents | Cancer patients | Care and treatment | Pharmacogenetics | Chemotherapy | Analysis | Colorectal cancer | Single nucleotide polymorphisms | Antineoplastic agents | Chromosomes | Cancer
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 11/2019, p. clincanres.3024.2019
To determine whether second-line therapy with capecitabine and temozolomide was superior to irinotecan, leucovorin, and fluorouracil (FOLFIRI) in patients with... 
Journal Article